METABOLIC THERAPY FOR PATIENTS WITH COEXISTING VISCERAL AND PERIODONTAL DISEASES

Introduction. Nowadays, many evidences about interrelation of inflammatory defeats of parodont and various internal diseases have been collected. Universal molecular and cellular deviations, violations of redox metabolism, pathological activation of apoptosis promote development and progressing of many somatic diseases and the inflammatory diseases of parodont associated with them.

The objective is to evaluate the efficacy of metabolic therapy in patients with coexisting visceral and periodontal diseases.

Materials and methods. 909 patients with visceral diseases associated with generalized periodontitis were examined totally. Group I consisted of 100 patients with chronic infection sites of different localization. Group II consisted of 100 patients with cardiovascular diseasesю Patients from group I and II were divided into two sub-groups, they were prescribed to take metabolic drugs – mexidol (ethylmethylhydroxypyridine succinate) or сycloferon (meglumine acridonacitate) and mildronate (meldonium dehydrate) or cytoflavin (drug succinic acid). Intensity of free radical oxidation in organism was assessed by the products of lipid peroxidation; oxidation of thiol-containing compounds – proteins and low-molecular thiols – was assessed by using direct and back amperometric titration; apoptosis was studied on the model of lymph cells using flow cytometry (Annexin V – FITC); the status of periodontium was assessed with definition of the periodontal index (PI) and community periodontal index of treatment needs (CPITN).

Results. The activity of lipid peroxidation and free radical oxidation of thiols (р<0.01), the level of markers of pathological apoptosis Annexinа V – FITC (р<0.05) were increased in patients with coexisting visceral and periodontal diseases. In the course of the treatment with different metabolic medicines, the activity of lipid peroxidation tended to slow down as identified in both groups of examined patients (p<0.01) and increase thiol-disulfide ratio. In the course of treatment with metabolic drug, the number of cells entering apoptotic phase in patients with visceral and periodontal diseases was significantly fewer (р<0.01).

Conclusions. Thus, the findings of the study demonstrate that the correction of specific deficiencies of homeostasis is accompanied by simultaneous correction of other homeostatic failures. Patient-specific approach in choosing the metabolic therapy for treatment of patients with coexisting visceral and periodontal diseases depends on the links of metabolic homeostasis where more significant deficiencies were revealed.

visceral diseases, periodontal diseases, metabolic therapy

1. Loesche W.J., Grossman N.S. Periodontal Disease as a Specific, albeit Chronic, Infection: Diagnosis and Treatment. Clin Microbiol Rev. 2001; vol. 14(4):727-52.

2. Irfan U.M., Dawson D.V., Bissada N.F. Epidemiology of periodontal disease: a review and clinical perspectives. J Int Acad Periodontol. 2001; vol. 3(1):14-21.

3. Albandar J.M. Epidemiology and risk factors of periodontal diseases. Dent Clin North Am. 2005; vol. 49(3):517-32.

4. Khan S., Saub R., Vaithilingam R.D., Safii S.H., Vethakkan S.R., Baharuddin N.A. Prevalence of chronic periodontitis in an obese population: a preliminary study. BMC Oral Health. 2015; vol. 15:114.

5. Seinost G., Wimmer G., Skerget M., Thaller E., Brodmann M., Gasser R., Bratschko R.O., Pilger E. Periodontal treatmenti mproves endothelial dysfunction in patients with severe periodontitis. Am Heart J. 2005; vol. 149(6):1050-4.

6. Tonetti M.S., D’Aiuto F., Nibali L., Donald A., Storry C., Parkar M., Suvan J., Hingorani A.D., Vallance P., Deanfield J. Treatment of periodontitis and endothelial function. N Engl J Med. 2007; vol. 356(9):911-20.

7. Ridker P.M., Silvertown J.D. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol. 2008; vol. 79 (8 Suppl):1544-51.

8. D’Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani A.D, Deanfield J, Tsakos G. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J. Clin Endocrinol Metab. 2008; vol. 93(10): 89-94.

9. Intorre F., Polito A, Andriollo-Sanchez M, Azzini E, Raguzzini A, Toti E, Zaccaria M, Catasta G, Meunier N, Ducros V, O’Connor JM, Coudray C, Roussel AM, Maiani G. Effect of zinc supplementation on vitamin status of middle-aged and older European adults: the ZENITH study. Eur J Clin Nutr. 2008; vol. 62(10):1215-23.

10. Teles R., Wang C.Y.Mechanisms involved in the association between periodontal diseases and cardiovascular disease. Oral Dis. 2011; vol. 17(5):450-61.

11. López N.J., Quintero A., Casanova P.A., Ibieta C.I., Baelum V., López R. Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a controlled clinical trial. J Periodontol. 2012; vol. 83(3):267-78.

12. Harshavardhana B., Rath S. K., Mukherjee M Evaluation of serum ceruloplasmin in aggressive and chronic periodontitis patients//Jndian Society Periodontology 2013; vol. 17(3): 333–337.

13. Kurita-Ochiai T., Jia R., Cai Y., Yamaguchi Y., Yamamoto M.. Periodontal Disease-Induced Atherosclerosis and Oxidative Stress. Antioxidants (Basel). 2015; vol. 4(3):577-90.

14. Zhang B. , Khalaf H. Sirsjö A., Bengtsson T. Gingipains from the Periodontal Pathogen Porphyromonas gingivalis Play a Significant Role in Regulation of Angiopoietin 1 and Angiopoietin 2 in Human Aortic Smooth Muscle Cells//Infection and Immunity. 2015; vol. 83(11).- 4256-65.

15. Martínez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol. 2005; vol. 288(3):H1004-9.

16. Gutiérrez-Venegas G., Guadarrama-Solís A., MuñozSeca C., Arreguín-Cano J.A.Hydrogen peroxide-induced apoptosis in human gingival fibroblasts.. Int J Clin Exp Pathol. 2015; vol. 8(12):15563-72.

17. Mignotte B., Vayssiere J.L. Mitochondria and apoptosis. Eur J Biochem. 1998; vol. 252(1):1-15.

18. Bhola P.D., Letai A. Mitochondria-Judges and Executioners of Cell Death Sentences Mol Cell. 2016; vol. 61(5):695-704.

19. Federico Tinti, Mena Soorya, Mechanisms for redox actions of nicotine and glutathione in cell culture, relevant to periodontitis. Sci Rep 2012. vol. 2: 566.

20. Matsuyama S., Llopis J, Deveraux Q.L, Tsien R.Y, Reed J.C. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol. 2000; vol. 2(6):318-25.

21. Rieger A.M., Nelson K,L., Konowalchuk J.D., Barreda D.R. Modified annexin V/propidium iodide apoptosis assay for accurate assessment of cell death. J Vis Exp. 2011; vol. 50: 2597.

22. Masataka S., Toshimitsu S.,Kenneth W., Toshimitsu S., Kenneth W.. Vascular Endothelial Cells and Smooth Muscle Cells Differ in Expression of Fas and FasL and in Sensitivity to FasL — Induced Cell Death . Arterioscler. Thromb. Vasc. Biol. 2000; Vol. 20: 309-16.

23. Smolewski P., Grabarek J., Halicka H.D., Darzynkiewicz Z. Assay of caspase activation in situ combined with probing plasma membrane integrity to detect three distinct stages of apoptosis.. J Immunol Methods. 2002; vol. 265(1-2):111-21.

24. Ramírez J.H., Arce R.M., Contreras A. Periodontal treatment effects on endothelial function and cardiovascular disease biomarkers in subjects with chronic periodontitis: protocol for a randomized clinical trial. Trials . 2011; vol. 12:46.

25. Saffi M.A., Furtado M.V., Montenegro M.M., Ribeiro I.W., Kampits C., Rabelo-Silva E.R., Polanczyk C.A., Rösing C.K., Haas A.N. The effect of periodontal therapy on C-reactive protein, endothelial function, lipids and proinflammatory biomarkers in patients with stable coronary artery disease: study protocol for a randomized controlled trial. Trials . 2013; vol. 14:283.

26. Sycheva Yu. A., Popov D. A., Gorbachev I. A., Orekhovo L.YU. Disturbances of a regionarny hemodynamics, a microcirculatory bed at patients with a heart failure with inflammatory diseases of a parodont \\Parodontologiya. - 2016. - T.XXI, 3 (80) - 27-31 pages.

27. Sokolovsky, V.V. Thiol disulfide system in the body reaction to environmental factors. St. Petersburg., 2008.